MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$130,888K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net proceeds from sale of real e...
Proceeds from borrowings
Collection of loan principal
Others
Negative Cash Flow Breakdown
Payments of borrowings
Gain on assets sold - net
Dividends paid
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
379,668
158,576
171,972
184,956
Depreciation and amortization
81,842
84,140
82,749
82,114
Impairment on real estate properties
0
392
6,016
1,144
Straight-line rent and other write-offs
7,385
2,377
446
27,537
(recovery) provision for credit losses
-5,019
-3,294
5,923
-3,908
Amortization of deferred financing costs and loss on debt extinguishment
3,404
3,404
-2,490
1,062
Stock-based compensation expense
23,451
10,592
9,866
9,277
Gain on assets sold - net
246,519
3,024
6,073
28,269
Straight-line rent and effective interest receivables
-
-
13,317
13,418
Straight-line receivables
9,800
13,215
-
-
Interest paid-in-kind
-5,370
-6,551
-4,244
-4,350
Loss from unconsolidated entities
2,281
3
446
2,622
Other non-cash items
-8,077
-522
15,747
6,176
Contractual receivables
-1,165
2,951
-2,835
1,006
Lease inducements
-
-
-226
-228
Other operating assets and liabilities
22,843
15,469
7,988
-2,438
Net cash provided by operating activities
217,722
215,502
230,620
226,714
Acquisition of real estate
101,109
124,995
55,185
67,422
Net proceeds from sale of real estate investments
525,221
34,488
18,715
81,066
Investments in construction in progress
3,796
4,064
2,110
1,748
Investment in loan receivables and other
29,824
112,205
32,688
31,115
Collection of loan principal
172,371
36,716
126,236
20,060
Investments in unconsolidated entities
182
96,996
44,844
75,994
Distributions from unconsolidated entities in excess of earnings
3,288
3,400
2,944
8,503
Capital improvements to real estate investments
17,913
8,758
26,693
21,235
Proceeds from foreign currency forward contracts
-243
-735
435
0
Receipts from insurance proceeds
3,756
1,666
2,353
4,086
Net cash provided by (used in) investing activities
552,055
-270,013
-11,707
-83,799
Proceeds from borrowings
408,000
719,000
641,000
0
Payments of long-term borrowings
-
-
1,896,758
-
Payments of borrowings
827,000
7,504
-
1,256
Payments of financing related costs
0
333
1,651
19,060
Net proceeds from issuance of common stock
61,428
104,882
-42
88,959
Dividends paid
200,025
198,420
198,391
198,211
(payments for) proceeds from derivative instruments
-
-
2,200
-
Redemption of omega op units
70,598
13,276
480
2,087
Distributions to omega op unit holders
10,948
21,530
10,437
7,395
Net cash (used in) provided by financing activities
-639,143
54,323
-940,463
-139,050
Effect of foreign currency translation on cash, cash equivalents and restricted cash
254
-1,054
1,109
-1,445
Increase in cash, cash equivalents and restricted cash
130,888
-1,242
-720,441
2,420
Cash, cash equivalents and restricted cash at beginning of period
53,321
54,563
775,004
548,735
Cash, cash equivalents and restricted cash at end of period
184,209
53,321
54,563
775,004
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
sale of real estate...
$525,221K
(187.01%↑ Y/Y)
Collection of loan
principal
$172,371K
(71.86%↑ Y/Y)
Net income
$379,668K
(50.34%↑ Y/Y)
Receipts from insurance
proceeds
$3,756K
(858.16%↑ Y/Y)
Distributions from
unconsolidated entities in...
$3,288K
(124.28%↑ Y/Y)
Proceeds from foreign
currency forward...
-$243K
(94.80%↑ Y/Y)
Depreciation and
amortization
$81,842K
(-48.97%↓ Y/Y)
Stock-based compensation
expense
$23,451K
(-6.37%↓ Y/Y)
Other non-cash items
-$8,077K
(-285.34%↓ Y/Y)
Straight-line rent and other
write-offs
$7,385K
(-73.18%↓ Y/Y)
Amortization of deferred
financing costs and loss on...
$3,404K
(42.07%↑ Y/Y)
Loss from
unconsolidated entities
$2,281K
(-25.60%↓ Y/Y)
Contractual receivables
-$1,165K
(-10.01%↓ Y/Y)
Net cash provided by
(used in) investing...
$552,055K
(224.26%↑ Y/Y)
Net cash provided by
operating activities
$217,722K
(-48.31%↓ Y/Y)
Effect of foreign
currency translation on...
$254K
(-95.51%↓ Y/Y)
Canceled cashflow
$152,824K
Canceled cashflow
$289,551K
Increase in cash, cash
equivalents and restricted...
$130,888K
(-41.53%↓ Y/Y)
Canceled cashflow
$639,143K
Acquisition of real estate
$101,109K
(-81.96%↓ Y/Y)
Investment in loan
receivables and other
$29,824K
(-72.83%↓ Y/Y)
Capital improvements to
real estate...
$17,913K
(-45.62%↓ Y/Y)
Investments in construction
in progress
$3,796K
(-87.23%↓ Y/Y)
Investments in
unconsolidated entities
$182K
(-85.44%↓ Y/Y)
Proceeds from borrowings
$408,000K
(-39.17%↓ Y/Y)
Net proceeds from
issuance of common stock
$61,428K
(-88.14%↓ Y/Y)
Gain on assets sold -
net
$246,519K
(647.91%↑ Y/Y)
Other operating
assets and liabilities
$22,843K
(360.85%↑ Y/Y)
Straight-line receivables
$9,800K
Interest paid-in-kind
-$5,370K
(-7.49%↓ Y/Y)
(recovery) provision for
credit losses
-$5,019K
(-1663.55%↓ Y/Y)
Net cash (used in)
provided by financing...
-$639,143K
(-364.92%↓ Y/Y)
Canceled cashflow
$469,428K
Payments of borrowings
$827,000K
(56.85%↑ Y/Y)
Dividends paid
$200,025K
(-47.88%↓ Y/Y)
Redemption of omega op units
$70,598K
(1817.90%↑ Y/Y)
Distributions to omega op unit
holders
$10,948K
(-57.98%↓ Y/Y)
Buy us a coffee
OMEGA HEALTHCARE INVESTORS INC (OHI)
OMEGA HEALTHCARE INVESTORS INC (OHI)